Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38% Market Closed
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Nexgel Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nexgel Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Nexgel Inc
NASDAQ:NXGL
Cash from Operating Activities
-$3.2m
CAGR 3-Years
-22%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Cash from Operating Activities
$85m
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
ICU Medical Inc
NASDAQ:ICUI
Cash from Operating Activities
$255.1m
CAGR 3-Years
-1%
CAGR 5-Years
20%
CAGR 10-Years
14%
Align Technology Inc
NASDAQ:ALGN
Cash from Operating Activities
$522.6m
CAGR 3-Years
-26%
CAGR 5-Years
-7%
CAGR 10-Years
9%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash from Operating Activities
$499.3m
CAGR 3-Years
131%
CAGR 5-Years
46%
CAGR 10-Years
46%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash from Operating Activities
$214.3m
CAGR 3-Years
16%
CAGR 5-Years
24%
CAGR 10-Years
16%
No Stocks Found

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.73 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Nexgel Inc's Cash from Operating Activities?
Cash from Operating Activities
-3.2m USD

Based on the financial report for Dec 31, 2023, Nexgel Inc's Cash from Operating Activities amounts to -3.2m USD.

What is Nexgel Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-16%

Over the last year, the Cash from Operating Activities growth was -8%. The average annual Cash from Operating Activities growth rates for Nexgel Inc have been -22% over the past three years , -16% over the past five years .

Back to Top